SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Update - Effective Date Of Appointment Of Mr. Rolf Hoffmann As An Independent Director
This is further to the intimation dated May 27, 2023, regarding appointment of Mr. Rolf Hoffmann as an Independent Director. In this connection, we would like to inform that the effective date of appointment of Mr. Rolf Hoffmann (DIN: 10200311) is June 15, 2023 i.e. date of allotment of Director Identification Number. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sun Pharma's growth prospects look healthy; analysts positive on the stock
Majority of analysts positive on the stock; their average target price indicates an upside potential of 15 per cent SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sun Pharma to increase R&D investment in specialty and generics businesses
Firm says its current generics pipeline for the US market includes 97 ANDAs, while 13 new drug applications are awaiting the US FDA's approval
Buy Sun Pharmaceutical Industries; target of Rs 1172: KR Choksey
KR Choksey is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1172 in its research report dated May 31, 2023. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q4 FY23 Earnings Call Transcript
Buy Sun Pharmaceutical Industries; target of Rs 1123: Sharekhan
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1123 in its research report dated May 29, 2023.